SURG · SurgePays, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“These conditions and events, considered in the aggregate, raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these consolidated financial statements are issued. Accordingly, management has concluded that its plans do not alleviate the substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Aug 19, 2026
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Telecom Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SURG
this stock
SurgePays, Inc.
|
$7.75M | -91.2% | -6.4% | — | 9.7% |
|
SFTBF
Softbank Group Corp.
|
$227.96B | +46.1% | — | — | 0.3% |
|
VZ
Verizon Communications Inc
|
$195.61B | +12.7% | +2.5% | 12.2 | 2.0% |
|
TMUS
T-Mobile US, Inc.
|
$177.45B | -19.4% | +8.3% | 17.3 | 1.7% |
|
T
At&T Inc.
|
$173.91B | -2.2% | +2.7% | 8.4 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SURG | +0.1% | -11.2% | -79.6% | -2.5% | -91.2% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | +0.4% | -10.7% | -91.8% | -3.4% | -104.1% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.